Nuzenio

Tradingview Mcrb

Tradingview Mcrb entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Seres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 14:41:21 GMTMCRB: Net loss of $42.2M and cash of $15.6M highlight urgent need for new funding by Q1 2027 - TradingViewTradingView · Wed, 05 Aug 2026 14:31:46 GMTSeres Therapeutics Q2 net income turns positive on VOWST sale gain - TradingViewTradingView · Wed, 05 Aug 2026 11:19:30 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTMCRB: Returned to profitability in Q2 2026, driven by VOWST sale gains and SER-155 trial success - TradingViewTradingView · Wed, 05 Aug 2026 11:12:40 GMTMCRB Q2'26 Earnings: EPS estimate is (2.19) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:38 GMT

Timeline

Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingView
Wed, 05 Aug 2026 14:31:46 GMTMCRB: Net loss of $42.2M and cash of $15.6M highlight urgent need for new funding by Q1 2027 - TradingView
Wed, 05 Aug 2026 11:19:30 GMTSeres Therapeutics Q2 net income turns positive on VOWST sale gain - TradingView
Wed, 05 Aug 2026 11:13:00 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingView
Wed, 05 Aug 2026 11:12:40 GMTMCRB: Returned to profitability in Q2 2026, driven by VOWST sale gains and SER-155 trial success - TradingView
Tue, 04 Aug 2026 11:01:38 GMTMCRB Q2'26 Earnings: EPS estimate is (2.19) USD - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Mcrb.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.